Sang Kim, MD

Yale University
Branford, CT, United States

Sang Kim, MD, PhD, is the Director of the Immunotherapy Adverse Events in Rheumatology Program at Yale University School of Medicine. He is a physician-scientist with a focus on rheumatology and human translational immunology. His research aims to understand the role of immune checkpoint receptors in normal physiology, autoimmune disorders, and cancer.

Presentation(s):

• Checkpoint Molecules and Pathogenesis of Autoimmune Disease

  Saturday, October 25, 2025
  9:00 AM – 9:30 AM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose